Actively hiring
Health Care
Rare Disease Therapeutics
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Overview
101 Therapeutics discovers and develops effective, easy-to-use, and well-tolerated therapies across oncology, autoimmune, metabolic, and rare diseases.
News
101 Therapeutics Releases Clinical Evidence Package for Macrophage-Targeted 101-PGC-005 and Seeks Urgent Independent Review for Bundibugyo Ebola Disease
TEL AVIV, Israel & ENGLEWOOD, N.J., June 19, 2026--101 Therapeutics releases evidence package for 101-PGC-005, seeking independent review for therapeutic use in Bundibugyo Ebola crisis.
Read more
Report
Star Tribune
Your source for Minnesota news today. Read articles, view photos or watch videos about news in Minneapolis, St. Paul, Duluth, St. Cloud, Rochester, and beyond.
Read more
Report
